Study S000750

Brain Systems and Behaviors Underlying Response to Obesity Treatment in Children

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04520490
Acronym: BASIC2
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: QUADRUPLE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 63
Start: 2021-01-28
Primary completion: 2025-08-21
Lead sponsor: Seattle Children's Hospital
Conditions: Childhood Obesity
Interventions: BEHAVIORAL:Family Based Behavioral Treatment; DRUG:Exenatide 2 mg [Bydureon]; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change of BMI z-score [Change from drug treatment randomization at week 8 of family-based behavioral treatment (FBT) to end of combined intervention (FBT + drug) at week 24 of FBT]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.